Samtasu (tolvaptan sodium phosphate) / Otsuka  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Samtasu (tolvaptan sodium phosphate) / Otsuka
NCT03962101: Safety Trial of OPC-61815 Injection in Patients With Congestive Heart Failure Who Have Difficulty With or Are Incapable of Oral Intake

Completed
3
45
Japan
OPC-61815 injection
Otsuka Pharmaceutical Co., Ltd.
Congestive Heart Failure
06/20
06/20
NCT03772041: Efficacy and Safety Trial of OPC-61815 Injection Compared With Tolvaptan 15-mg Tablet in Patients With Congestive Heart Failure

Completed
3
294
Japan
OPC-61815, Tolvaptan Tab 15 MG
Otsuka Pharmaceutical Co., Ltd.
Congestive Heart Failure
07/20
07/20

Download Options